In vitro activity of fosfomycin-gentamicin, fosfomycin-ceftazidime, fosfomycin-imipenem and ceftazidime-gentamicin combinations against ceftazidime-resistant Pseudomonas aeruginosa

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 36, Issue 5, 2005, Pages 1239-1242

  Pruekprasert, Pornpimol ^a   Tunyapanit, Wanutsanun ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 30344461017     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Cavallo JD, Fabre R, Leblanc F, Nicolas-Chanoine MH, Thabaut A, The GERPB. Antibiotic susceptibility and mechanisms of β-lactam resistance in 1,310 strains of Pseudomonas aeruginosa: a French multicentre study (1996). J Antimicrob Chemother 2000; 46: 133-6.
2. Chen HY, Yuan M, Ibrahim-Elmagboul IB, Livermore DM. National survey of susceptibility to antimicrobials amongst clinical isolates of Pseudomonas aeruginosa. J Antimicrob Chemother 1995; 35: 521-34.
3. Chin NX, Neu NM, Neu HC. Synergy of fosfomycin with beta-lactam antibiotics against Staphylococci and aerobic gram-negative bacilli. Drugs Expt Clin Res 1986; 12: 943-7.
4. Hallander HO, Dornbusch K, Gezelius L, Jacobson K, Karlsson I. Synergism between aminoglycosides and cephalosporins with antipseudomonal activity: interaction index and killing curve method. Antimicrob Agents Chemother 1982; 22: 743-52.
5. Hayami H, Goto T, Kawahara M, Ohi Y. Activities of β-lactams, fluoroquinolones, amikacin and fosfomycin alone and in combination against Pseudomonas aeruginosa isolated from complicated urinary tract infections. J Infect Chemother 1999; 5: 130-8.
6. Hilf M, Yu VL, Sharp J, Zuravleff JJ, Korvick JA, Muder RR. Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am J Med 1989; 87: 540-6.
7. Kahan FM, Kahan JS, Cassidy PJ, Kropp H. The mechanism of action of fosfomycin. Ann NY Acad Sci 1974; 235-364.
8. Korvick JA, Yu VL. Antimicrobial agent therapy for Pseudomonas aeruginosa. Antimicrob Agents Chemother 1991; 35: 2167-72.
9. th ed. Informational supplement M100-S9. Wayne Pa: NCCLS, 1999.
10. Oie S, Sawa A, Kamiya A, Mizuno H. In vitro effects of a combination of antipseudomonal antibiotics against multi-drug resistant Pseudomonas aeruginosa. J Antimicrob Chemother 1999; 44: 689-91.
11. Okazaki M, Suzuki K, Asano N, et al. Effectiveness of fosfomycin combined with other antimicrobial agents against multidrug-resistant Pseudomonas aeruginosa isolates using the efficacy time index assay. J Infect Chemother 2002; 8: 37-42.
12. Olay TA, Rodriguez A, Oliver LE, Vincente MV, Oueredo MCR. Interaction of fosfomycin with other antimicrobial agents: in vitro and vivo studies. J Antimicrob Chemother 1978; 4: 569-76.
13. Premru MM, Zupanc TL. Epidemiological typing of imipenem-resistant Pseudomonas aeruginosa. Int J Antimicrob Agents 2002; 20: 380-3.
14. Takahashi K, Kanno H. Synergistic activities of combination of betalactams, fosfomycin, and tobramycin against Pseudomonas aeruginosa. Antimicrob Agents Chemother 1984; 26: 789.